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Abstract
Background: Successful weight maintenance following weight loss is challenging for many people. Identifying predictors of
longer-term success will help target clinical resources more effectively. To date, focus has been predominantly on the
identification of predictors of weight loss. The goal of the current study was to determine if changes in anthropometric and
clinical parameters during acute weight loss are associated with subsequent weight regain.
Methodology: The study consisted of an 8-week low calorie diet (LCD) followed by a 6-month weight maintenance phase.
Anthropometric and clinical parameters were analyzed before and after the LCD in the 285 participants (112 men, 173
women) who regained weight during the weight maintenance phase. Mixed model ANOVA, Spearman correlation, and
linear regression were used to study the relationships between clinical measurements and weight regain.
Principal Findings: Gender differences were observed for body weight and several clinical parameters at both baseline and
during the LCD-induced weight loss phase. LCD-induced changes in BMI (Spearman’s r= 0.22, p = 0.0002) were inversely
associated with weight regain in both men and women. LCD-induced changes in fasting insulin (r= 0.18, p = 0.0043) and
HOMA-IR (r= 0.19, p = 0.0023) were also associated independently with weight regain in both genders. The aforementioned
associations remained statistically significant in regression models taking account of variables known to independently
influence body weight.
Conclusions/Significance: LCD-induced changes in BMI, fasting insulin, and HOMA-IR are inversely associated with weight
regain in the 6-month period following weight loss.
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Introduction
Obesity is recognized as a primary risk factor for cardiovascular
disease, hypertension, type 2 diabetes, musculoskeletal disorders,
and some cancers [1]. Weight loss has been demonstrated to
reduce the risk of these obesity-related complications [2]. While
losing weight is relatively easy, maintaining a reduced body weight
has proved challenging for many individuals [3]. Because of the
inherent variability in successful long-term weight reduction, there
is considerable interest to identify predictors/indicators of weight
regain.
Successful weight maintenance can be defined as maintaining
an intentional 10% reduction in body weight for a minimum of
one year [4]. A recent review of 42 randomized clinical trials of
weight loss maintenance reported that pharmacotherapy coupled
with lifestyle modifications resulted in less weight regain following
a weight loss phase [5]. However, considerable variability in
weight regain was observed between people, irrespective of the
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intervention. This reinforces the relevance of identifying predictors
of weight regain.
To date, most of the focus regarding the identification of
predictors for body weight changes has examined weight loss
rather than weight maintenance and/or regain. A number of
factors are currently being studied for their potential to predict
weight maintenance, including behavioural, anthropometric,
clinical, genetic, and molecular parameters. Many of the
behavioural and anthropometric parameters commonly used to
predict changes in body weight are obtained through general
surveys and interviews at various stages during a clinical
intervention. Factors such as the degree of weight loss [6],
physical activity [7], diet composition [8], and internal disinhi-
bition [9] are potentially useful indicators for weight maintenance
and/or regain that are relatively straightforward to obtain. In
contrast, research studying the predictive capabilities of clinical,
genetic, and molecular parameters is less common because their
analysis is often dependent on expensive and highly dedicated
apparatus. Nevertheless, candidate molecular predictors are
beginning to appear in the literature and include single
nucleotide polymorphisms in key adipose tissue genes [10],
plasma protein concentrations [11,12], and circulating steroid
hormones [13]. A recent study by several of the co-authors
reported that the expression of genes regulating fatty acid
metabolism, the citric acid cycle, oxidative phosphorylation, and
apoptosis differed during a caloric restriction phase between
women who successfully maintain weight loss and women who
regain weight [14]. Furthermore, this study also postulated that
reduced insulin secretion may be a potential indicator of
successful short-term weight maintenance.
The goal of the current study was to determine if common
clinical parameters measured during an 8-week weight loss
intervention were associated with weight regain during a 6-month
follow-up period [15,16]. More specifically, we examined the
relationships between baseline (i.e. before the low-calorie diet;
LCD) clinical parameters (e.g. BMI, fasting insulin, fasting glucose,
etc.) and weight regain, as well as LCD-induced changes in these
parameters, in order to determine the value of these measurements
as potential predictors of weight maintenance. In light of the
growing body of evidence demonstrating molecular differences
between subjects who experience weight regain and those with
continued weight loss [13,17,18], the current investigation focused
only on those individuals who experienced weight regain during
the weight maintenance phase.
Methods
Diet Intervention Study
This study is part of the European Framework VI project
DiOGenes (Diet, Obesity, and Genes). Larsen et al [16] and
Moore et al [15] have previously provided a detailed description
of the DiOGenes project objectives and goals. Briefly, the
intervention study consisted of two phases: an initial 8-week
weight loss phase followed by a 6-month weight maintenance
phase. The weight loss phase consisted of a low calorie diet
(LCD; 3300 kJ/d; ,800 kcal; ModifastH; Nutrition et Sante´,
Revel, France). Weight loss of at least 8% baseline body weight
was required in order for participants to continue into the
weight maintenance phase of the study. As outlined in Larsen et
al [16], participants who achieved the required weight loss were
randomized into one of five diet groups for the weight
maintenance phase. Energy intake and physical activity were
strictly controlled during the LCD phase but, during the weight
maintenance phase, subjects only received dietary counselling
and were allowed to eat ad libitum. The five ad libitum diet
groups consisted of a control diet and four low-fat (20–25%
energy intake) diets that varied in protein content (P) and
glycemic index (GI): low GI (LGI)/low P (LP), high GI (HGI)/
LP, LGI/high P (HP), or HGI/HP. Target energy intakes in
the LP diets were 10–15% protein and 57–62% carbohydrates,
and in the HP diets were 23–28% protein and 45–50%
carbohydrates. The goal was to achieve a difference of
approximately 15 GI points between the LGI and HGI diets.
The participants met with a dietician at regular intervals during
the 6-month weight maintenance phase.
Subject Selection
A total of 932 overweight and obese Caucasian adults were
recruited from 8 study centres across Europe. In all, 546
participants completed the entire diet intervention study (Fig. 1).
Participant data was filtered for missing body weight measure-
ments; body weight measurements were required at the three
clinical investigation days: CID1 (prior to commencing the LCD),
CID2 (at the end of the LCD phase), and CID3 (at the end of the
6-month weight maintenance phase). After filtering for missing
values, a total of 502 subjects remained. Finally, only subjects who
experienced weight regain were considered. Relative weight regain
was calculated as previously defined [13,17]:
Relative weight regain~
weight at CID3{ weight at CID2
weight at CID1{ weight at CID2
This left a final number of 285 subjects who met the inclusion
criteria: 112 males and 173 females. The subjects used for the
current study were evenly distributed amongst the five weight
maintenance diet groups.
Blood Sampling
Fasted blood samples were collected at each of the three clinical
investigation days (CID) for the analysis of blood clinical
parameters related to lipid and glucose metabolism (listed in
detail below) [16]. In addition, an oral glucose tolerance test
(OGTT) lasting 120 minutes was conducted at each CID after the
consumption of 75 g of glucose. Insulin secretion and glucose
response were determined by calculating the area under the curve
(AUC) using the trapezoid rule; a method previously described by
Matthews et al [19].
Statistical Methods
A mixed-model ANOVA using the restricted maximum
likelihood (REML) method was generated using gender (male;
female), time (CID1; CID2), the interaction between gender and
time (gender 6 time) as fixed effects, and the subject ID as a
random effect (to account for repeated measurements). Least
squares means response values were estimated for gender-by-time
conditions. The ANOVA model was used to examine anthropo-
metric and clinical parameters at baseline (CID1) and after the 8-
week LCD phase (CID2). Weight (kg), BMI (kg/m2), fat
percentage, and fasting values for total cholesterol (mmol/L),
HDL (mmol/L), triglycerides (mmol/L), insulin (mIU/mL), and
glucose (mmol/L) were compared. Insulin resistance (HOMA-IR),
insulin secretion (mIU N min N mL21), and glucose response (mmol/
L N min N mL21) were also examined. Post-hoc F-tests were
subsequently used to examine the fixed effects of gender and time.
Spearman correlations (r) were calculated to examine the
associations between various anthropometric and clinical
parameters (BMI, HOMA-IR, fasting insulin, insulin AUC,
Clinical Markers Associated with Weight Regain
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fasting glucose, and glucose AUC) and weight regain. For each
parameter, we examined both the baseline and differential
values (i.e. the difference between before and after the LCD;
DCID2-CID1) for their relationship with weight regain.
Finally, linear regression was performed in order to account for
the influence of various covariates that may independently affect
weight regain. Regression variables included age, sex, recruitment
centre, the randomized diet group, baseline energy intake and
baseline physical activity (PA) as fixed effects. BMI was included as
a covariate in the models examining insulin and glucose
parameters. PA at CID1 was determined by calculating the sum
of the individual Baeck index scores [20] at CID1 for each
participant prior to commencing the study. Baseline energy intake
values were log-transformed prior to regression analysis to remove
skewness. R2 values and F-tests were used to determine how much
variation was accounted for when predicting weight regain using
the regression models.
All statistical analyses were performed using JMP Genomics
(Version 5, SAS, Cary, NC, USA). A significance level of a=0.05
was used.
Results
Anthropometric and Clinical Measurements during the
Protocol
A total of 285 subjects (112 men and 173 women) regained
weight during the 6-month follow-up period (i.e. .0% relative
weight regain). The mean age of the 285 subjects was
42.566.1 years. We examined numerous clinical parameters in
our population and found that most variables showed statistically
significant differences for gender and time, as well as pronounced
interaction between these two fixed effects, during the weight loss
phase of the study (Table 1).
Figure 2 highlights the differences in clinical measures between
men and women with respect to LCD-induced changes (i.e.
DCID2-CID1). At CID1, all clinical parameters except fasting
total cholesterol were statistically significantly different between
genders (data not shown). At CID2 some of these differences were
no longer statistically significant; namely fasting triglycerides,
fasting insulin, HOMA-IR, insulin secretion, and glucose response
(data not shown). All LCD-induced changes in clinical parameters
except fat percentage and fasting glucose were statistically
significantly different between genders (Fig. 2).
Figure 1. Flowchart for subject selection from the DiOGenes cohort.
doi:10.1371/journal.pone.0042858.g001
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Associations between Clinical Parameters and Relative
Weight Regain
Baseline BMI was not statistically significantly associated with
relative weight regain (Spearman’s r=20.0789, p= 0.1842)
(Fig. 3A); however, a statistically significant inverse correlation
was found between DBMI and relative weight regain (r=0.2199,
p = 0.0002) (Fig. 3B). More specifically, individuals who experi-
enced larger reductions in BMI during the LCD were found to
experience lower weight regain during the 6-month follow-up
period. Statistically significant associations were also identified
between insulin-related parameters and weight regain. The
Dfasting insulin (r=0.1770, p = 0.0043) and DHOMA-IR
(r=0.1905, p = 0.0023) values were each inversely correlated
with relative weight regain (Fig. 3D and F). In other words,
individuals who experienced larger reductions in insulin-related
measurements (i.e. greater improvements in insulin sensitivity)
were found to experience lower weight regain. The baseline values
corresponding to the aforementioned insulin-related measure-
ments were not correlated with relative weight regain (Fig. 3C and
E). Additionally, no statistically significant relationships were
identified between insulin AUC (either baseline or differential
data) and relative weight regain (data not shown). Finally,
correlation analyses revealed no statistically significant associations
between glucose-related parameters and weight regain (Fig. 3G
and H), although Dfasting glucose was borderline statistically
significant (r=0.1083, p = 0.0730).
Multiple factors result in weight regain. Therefore, we
examined the previous associations using regression models that
included age, sex, recruitment centre, the randomized diet group,
and baseline energy intake and PA as fixed effects. Our analyses
indicated that neither the recruitment centre nor the randomized
diet group were associated with weight regain; therefore, they were
omitted from the regression models in order to minimize the risk of
over-adjustment. In the subsequent regression models, the clinical
parameters previously mentioned remained statistically signifi-
cantly associated with weight regain. After adjusting for covariates,
DBMI remained statistically significantly and inversely associated
with relative weight regain (p,0.0001). Similarly, Dfasting insulin
and DHOMA-IR remained statistically significantly and inversely
associated with relative weight regain, independent of BMI
(p = 0.0175 and p= 0.0157, respectively). This means that
individuals who experienced greater reductions in BMI or greater
improvements in insulin sensitivity during the LCD were found to
experience lower weight regain. While Dfasting insulin and
DHOMA-IR are related (i.e. fasting insulin values are used to
calculate HOMA-IR), the relationship between insulin sensitivity
and weight regain were independent of BMI. The borderline
Dfasting glucose result identified with the correlation analysis was
not statistically significant after accounting for covariates
(p = 0.2276), indicating that changes in fasting glucose are not
associated with weight regain.
The aforementioned statistically significant regression models
were found to explain between 11–13% of the variation in relative
weight regain: DBMI had R2=0.110 (F-test p,0.0001), Dfasting
insulin had R2= 0.130 (F-test p,0.0001), and DHOMA-IR had
R2= 0.134 (F-test p,0.0001).
Discussion
The goal of this research was to determine if routine clinical
measurements taken before and after a LCD could serve as
potential predictors of subsequent weight regain for both men and
women. We demonstrated that larger reductions in BMI, fasting
insulin, or HOMA-IR during the LCD phase were associated with
reduced weight regain during the 6-month follow-up period.
Importantly, the relationship between insulin sensitivity and
weight regain was independent of changes in BMI. In contrast,
baseline measurements alone appear to have minimal use as
predictors of weight regain. Taken together, this finding suggests
that the magnitude of changes in body weight and insulin
sensitivity during weight loss have the potential to be indicative of
short-term weight regain.
Weight loss (DBMI) during the LCD phase remained a
statistically significant predictor of short-term weight regain even
after accounting for baseline differences in energy intake and
Table 1. Changes in anthropometric & clinical parameters during intervention.
Parameter CID1 (mean±SE)b CID2 (mean±SE)b Effect
time gender time6gender
Weight (kg) 100.0860.94 89.0960.94 ,0.0001a ,0.0001a ,0.0001a
BMI (kg/m2) 33.6660.28 29.9860.28 ,0.0001a 0.2781 0.0099a
Fat % 37.4560.39 33.6060.39 ,0.0001a ,0.0001a 0.7680
HOMA-IR 3.0660.09 1.7960.10 ,0.0001a 0.0005a 0.0005a
Fasting insulin (mIU/mL) 11.3960.32 7.2160.34 ,0.0001a 0.0011a 0.0003a
Fasting glucose (mmol/L) 5.1460.03 4.7960.03 ,0.0001a 0.0053a 0.4564
Insulin secretion (mIU N min N mL21) 8374.26235.0 5630.36246.8 ,0.0001a 0.0001a 0.0003a
Glucose response (mmol/L N min N mL21) 916.2611.5 868.7611.7 ,0.0001a 0.0314a 0.0366a
Fasting total cholesterol (mmol/L) 4.8860.06 4.1560.06 ,0.0001a 0.5727 0.0048a
Fasting triglycerides (mmol/L) 1.4360.04 1.0460.04 ,0.0001a ,0.0001a ,0.0001a
Fasting HDL-cholesterol (mmol/L) 1.1860.02 1.1360.02 0.0003a ,0.0001a ,0.0001a
Abbreviations: CID, clinical investigation day.
A mixed model ANOVA analysis using the REML method was used to study the effects of time and gender, as well as the interaction between time6 gender, on
anthropometric and clinical parameters before (i.e. CID1) and after (i.e. CID2) the LCD phase. The model was adjusted for covariates (age, baseline physical activity, and
baseline energy intake). The Effect columns indicate the p-values after performing a post-hoc fixed effects F test.
ap,0.05 was considered statistically significant.
bMean 6 SE represents least squares means 6 standard error.
doi:10.1371/journal.pone.0042858.t001
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Figure 2. Differences in anthropometric and clinical parameters between women and men. Box plots depicting LCD induced changes (i.e.
DCID2-CID1) in anthropometric and clinical parameters for females (white) and males (grey). ap,0.05 between male and female values when
conducting Student’s t-tests was considered statistically significant.
doi:10.1371/journal.pone.0042858.g002
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physical activity. This is an interesting finding that contributes to
the current discussion regarding whether the amount of weight lost
and the speed at which this weight is lost may be associated with
weight maintenance. Our findings are in agreement with several
previously published studies [21,22,23,24]. Jeffery et al conducted
a weight loss study and observed that the degree of initial weight
loss was positively associated with weight loss at 30 months [23].
Similarly, Anderson et al conducted a meta-analysis which
examined long-term weight maintenance (4–5 years) in individuals
who completed a structured weight loss program and reported that
a weight loss of $20 kg resulted in lower weight regain [21].
Handjieva-Darlenska et al reported a multivariate model in which
the consideration of weight loss at weeks 1, 3 and 8 of the LCD
phase explained 51% of the variation in weight loss maintenance
in the DiOGenes cohort [25]. This previous analysis differed from
the current study in that Handjieva-Darlenska and colleagues built
a predictive model using multiple weight measurements during the
weight loss period. Furthermore, the previous study included
individuals experiencing weight regain and continued weight loss
during the weight maintenance phase, whereas we focused solely
on individuals experiencing weight regain. The fact that we report
concordant findings using a different modeling approach strength-
ens the findings of both studies. Finally, a recent study termed the
Weight Loss Maintenance trial consisted of a 6-month lifestyle/
behavioural weight loss intervention phase followed by one of
three 30-month weight maintenance interventions in order to
examine the effectiveness of different strategies for sustained
weight loss in a population at risk for cardiovascular disease [22].
The authors examined the influence of physical activity, social
support, and diet quality on weight maintenance and concluded
that only weight loss during the weight loss intervention phase
positively predicted successful weight maintenance after 3 years.
Therefore, our data contributes to the notion that greater weight
loss during a weight loss intervention reduces an individual’s
propensity for weight regain, at least in the short-term. It is
interesting to note that we did not observe statistically significant
differences in relative weight regain between men and women,
despite detecting statistically significant gender differences in body
weight reductions during the LCD. Gender differences in body
weight changes during a weight loss intervention have been
previously reported in several studies, where men typically lose
more body weight than women. This has been partly attributed to
gender differences in body composition, reproductive hormones,
and appetite control [26,27,28]. The fact that we did not detect
gender differences in relative weight regain suggests distinct
molecular mechanisms may coordinate positive versus negative
changes in body weight.
We also report that certain insulin-related parameters may have
value for predicting weight regain. More specifically, we found
that greater LCD-induced decreases in fasting insulin and
HOMA-IR values were associated with reduced weight regain
independent of changes in BMI. This indicates that individuals
who experience a greater improvement in insulin sensitivity in
response to a weight loss intervention experienced lower weight
regain, similar to the conclusions of Yost et al. [29]. Such
improvements in insulin sensitivity have been linked to the concept
of metabolic flexibility, which refers to an individual’s ability to
switch between fat and glucose as sources of fuel [30]. The more
efficient this switch is, the greater the improvement in insulin
sensitivity. Thus greater improvements in insulin sensitivity may
reflect an individual’s propensity to be metabolically flexible.
Raatz et al conducted a study where 29 obese subjects were
randomized to 1 of 3 hypocaloric diets and reported that insulin
sensitivity improved in all subjects following caloric restriction
[31]. Moreover, during the following 24-week ‘‘free living’’ phase,
all subjects maintained their weight loss and their improved insulin
sensitivity. While the authors did not examine the association
between changes in insulin sensitivity and weight regain, they
suggest that diet composition may have a minor impact on weight
loss and/or weight maintenance. Rather, it seems that the
substantial improvements in insulin sensitivity, irrespective of diet,
may be more important for minimizing weight regain. The
findings of our study agree with those or Raatz et al. Another
study, conducted by Ross et al, found an association between
weight loss and reduced insulin resistance after a non-calorie-
restricting exercise intervention [32]; however, the authors
conducted their study in an all-female cohort and did not consider
a follow-up period. Taken together, these studies suggest that
improved insulin sensitivity may be a salient feature for limiting
weight regain, and that the manner in which this improvement is
achieved may be of secondary importance (i.e. energy restriction
or increased physical activity).
A previous study by several of the co-authors reported that
reductions in insulin secretion (i.e. insulin AUC) were associated
with weight maintenance [14]. This prior study examined 40
women who were classified as weight maintainers (0–10% relative
weight regain) or weight regainers (50–100% relative weight
regain). The current study has increased the population size,
considered both genders, and did not classify subjects into distinct
groups; thus we examined the association between changes in
insulin secretion experienced during the LCD and weight regain in
a more representative population. We failed to replicate the
statistical significance of our original finding, indicating that
efficacy of insulin secretion as a predictor of weight maintenance
in the general population remains unclear. Thus the use of insulin
secretion as an indicator of body weight changes warrants
continued exploration.
We did not find any evidence that glucose markers were
associated with weight regain. In contrast, a study by Boule´ et al
reported that lower glucose levels at 120 minutes of the OGTT
were associated with greater weight regain after 81 weeks in study
participants who followed a 15-week diet-induced weight loss
intervention [33]. Another study conducted in Pima Indians, in
which the authors studied changes in body weight, reported that a
greater glucose response to an OGTT was associated with lower
weight gain; however, the authors did not examine weight
maintenance [34]. Taken together, the associations between
glucose-related measurements and weight regain appear unclear.
Moreover, it is difficult to directly compare these studies with our
study because of differences in study designs and recruited
populations.
A review by Turk et al highlighted the fact that although many
human studies examining body weight changes have been
performed, results may not always be widely applicable because
the majority of these past studies used only females [5].
Furthermore, those studies that considered both genders tended
Figure 3. The relationship between clinical parameters and weight regain. The association between BMI (A, B), fasting insulin (C, D), HOMA-
IR (E, F), and fasting glucose (G, H) and relative weight regain were assessed by Spearman’s r correlation analysis. A, C, E, and G illustrate the
relationship between baseline CID1 parameters and weight regain, while B, D, F, and H illustrate the relationship between differential parameters (i.e.
DCID2-CID1) and weight regain. Relative weight regain = 1 represents a 100% regain in body weight. ap,0.05 was considered statistically significant.
doi:10.1371/journal.pone.0042858.g003
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to focus primarily on weight loss and not weight maintenance
[35,36]. For example, data from the European Prospective
Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort
revealed that high levels of consumption of food items high in
either sugar or fat predicted 2-year body weight changes in men or
women, respectively [35]. Another study that explored potential
baseline outcome predictors of a 12-week very-low-energy diet
(anthropometry, socioeconomic variables, established question-
naires on health-related quality of life and eating behaviour, and
additional diet-related questions) found that predictors of weight
loss after a 12-week very low calorie diet varied by gender,
specifically with regards to perceived physical health, social
interaction, socio-economic factors, and obesity-related psychoso-
cial problems [36]. Finally, recent reports suggest that differences
in hormone signalling, such as leptin and ghrelin, may also
contribute to gender differences in weight loss [37,38]. Our
statistical analyses were distinct to these past studies in that we
considered both genders and focussed on the association between
various clinical parameters and relative weight regain after a
weight loss intervention. While we observed gender differences
during the weight loss phase of the intervention, there was no
statistical evidence of gender differences in the clinical markers
studied during the weight maintenance phase.
The findings of the current study are promising to help target
clinical resources more effectively; however, it is important to
acknowledge that the 6-month follow-up period is considered
relatively ‘‘short-term’’ and that the clinical parameters found to
be associated with weight regain in our study need to be confirmed
in studies with a longer follow-up period. Furthermore, the precise
cause(s) for weight regain during the weight maintenance phase is
unclear, and is most likely a complex interaction between
behaviour, dietary habits, and physical activity, as well as genetic
and molecular factors. We used 3-day dietary records and
pedometers to estimate dietary habits and physical activity,
respectively [8]; however there are caveats to consider with both
of these factors. Firstly, food records are widely recognized to have
limitations, such as under-reporting food intake and portion size
[39,40], particularly in the obese. It is therefore possible that
inaccurate food records may mask subtle differences in caloric
intake between participants that over the course of the 6-month
period could contribute to weight regain. Secondly, changes in
physical activity habits may also partly explain the weight regain
observed in our study; however, we are unable to address this
point with confidence due to incomplete data regarding physical
activity. The contribution of such factors is evidenced in our
results, as the R2 of the linear regression models indicated that the
models explained less than 14% of the variability in weight regain,
suggesting that additional factors regulating weight maintenance
are involved. It is also noteworthy that there is considerable
variability in the data and that we are reporting statistically
significant relationships within a population; as such, the clinical
relevance of these predictors in other populations or for any one
individual remains to be demonstrated. Nevertheless, our results
suggest the importance of continuing and replicating this line of
research.
In summary, our study indicated that large reductions in BMI
and greater improvements in insulin sensitivity during an energy
restriction phase are associated with lower weight regain. This
work contributes to the growing body of research aimed at
unravelling the determinants of weight maintenance.
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